This data suggests that CXCR4+ST2+ Treg cells are majorily found in the BM during leukemia progression and in agreement with the report that blocking migration of Treg cells with AMD3100 (a CXCR4 inhibitor) delays disease progression in the MLL-AF9 induced leukemia model41. The gene discussed is KMT2A; the disease is leukemia.